Envisagenics Company
Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.
Investors
Technology:
Artificial Intelligence, Bioinformatics, Biotechnology, Machine Learning, Therapeutics
Industry:
AI, Early Drug Development, United States
Headquarters:
New York, New York, United States
Founded Date:
2014-04-22
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
16
Total Funding:
27056626
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-08-02
Last Funding Type:
Grant
Register and Claim Ownership